CVE-2026-50034 Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information
Attackers within Bluetooth range can intercept cleartext traffic to steal sensitive glucose measurement data from the device.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Local or same network only
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2026-50034?
CVE-2026-50034 is a high-severity vulnerability in Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT), published on 18 Jun 2026. It can only be exploited from the same machine or local network, with no action from the victim.
Official description
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
Weakness: CWE-319
Which versions are affected by CVE-2026-50034?
How do I fix CVE-2026-50034?
No fix has been published for CVE-2026-50034 yet. Limit exposure of the affected software until one is available.
Is CVE-2026-50034 being exploited?
There is no known exploitation of CVE-2026-50034 in the wild and no public exploit code.
Sources
Also known as GHSA-cmv8-9pgg-5rx4.